195 related articles for article (PubMed ID: 6183902)
21. [Effects of a massive dosage of methotrexate and leucovorin rescue therapy on acute leukemia and malignant lymphoma].
Gan To Kagaku Ryoho; 1982 Mar; 9(3):421-32. PubMed ID: 6764106
[TBL] [Abstract][Full Text] [Related]
22. New "rescue" with massive doses of citrovorum factor for potentially lethal methotrexate toxicity.
Djerassi I; Kim JS; Nayak N; Ohanissian H; Adler S; Hsieh S
Cancer Treat Rep; 1977 Jul; 61(4):749-50. PubMed ID: 301784
[No Abstract] [Full Text] [Related]
23. High-dose methotrexate-citrovorum factor rescue in the management of brain tumors.
Djerassi I; Kim JS; Shulman K
Cancer Treat Rep; 1977 Jul; 61(4):691-4. PubMed ID: 301782
[No Abstract] [Full Text] [Related]
24. Methotrexate hepatotoxicity in psoriasis--comparison of different dose regimens.
Dahl MG; Gregory MM; Scheuer PJ
Br Med J; 1972 Mar; 1(5801):654-6. PubMed ID: 5015292
[TBL] [Abstract][Full Text] [Related]
25. Painful erosions on psoriatic plaques: cutaneous clue to life-threatening methotrexate overdose.
Bishnoi A; Guliani A; Narang T; Dogra S
Postgrad Med J; 2019 Nov; 95(1129):619-620. PubMed ID: 31227639
[No Abstract] [Full Text] [Related]
26. Methotrexate in psoriatic arthritis.
Singh YN; Verma KK; Kumar A; Malaviya AN
J Assoc Physicians India; 1994 Nov; 42(11):860-2. PubMed ID: 7868484
[TBL] [Abstract][Full Text] [Related]
27. [Experience with methotrexate in the management of psoriasis].
Mazzi R
Dermatologica; 1969; 139(4):298-300. PubMed ID: 5374668
[No Abstract] [Full Text] [Related]
28. [Disturbances of coagulation following high-dosage methotrexate with citrovorum factor rescue in patients with osteogenous sarcoma. (author's transl)].
Göbel U; Jürgens H; von Voss H; Wahn V; Rosen G
Klin Padiatr; 1981 Mar; 193(2):94-8. PubMed ID: 6971958
[No Abstract] [Full Text] [Related]
29. Sequential methotrexate and 5-FU in the treatment of colorectal cancer.
Weinerman B; Schacter B; Schipper H; Bowman D; Levitt M
Cancer Treat Rep; 1982 Jul; 66(7):1553-5. PubMed ID: 6980048
[TBL] [Abstract][Full Text] [Related]
30. [Experiences with enterally and parenterally applied leucovorin following therapy with high doses of methotrexate in malignant tumors (author's transl)].
Vahrson H; Gorges K
Med Klin; 1976 Oct; 71(41):1720-3. PubMed ID: 1086422
[TBL] [Abstract][Full Text] [Related]
31. Randomized comparison of moderate-dose methotrexate infusions to oral methotrexate in children with intermediate risk acute lymphoblastic leukemia: a Childrens Cancer Group study.
Lange BJ; Blatt J; Sather HN; Meadows AT
Med Pediatr Oncol; 1996 Jul; 27(1):15-20. PubMed ID: 8614385
[TBL] [Abstract][Full Text] [Related]
32. Phase I trial of paclitaxel, carboplatin, and methotrexate with granulocyte colony-stimulating factor and leucovorin in advanced transitional cell carcinoma.
Edelman MJ; Meyers FJ; Houston J; Lauder I
Semin Oncol; 1997 Oct; 24(5 Suppl 15):S15-68-S15-71. PubMed ID: 9346226
[TBL] [Abstract][Full Text] [Related]
33. Psoriasis-liver-methotrexate interactions.
Arch Dermatol; 1973 Jul; 108(1):36-42. PubMed ID: 4716740
[No Abstract] [Full Text] [Related]
34. Clinical trials and pharmacokinetics of intermittent high-dose methotrexate-"leucovorin rescue" for children with malignant tumors.
Pratt CB; Roberts D; Shanks EC; Warmath EL
Cancer Res; 1974 Dec; 34(12):3326-31. PubMed ID: 4547680
[No Abstract] [Full Text] [Related]
35. Pulmonary and hepatic complications of methotrexate therapy of psoriasis.
Filip DJ; Logue GL; Harle TS; Farrar WH
JAMA; 1971 May; 216(5):881-2. PubMed ID: 5108291
[No Abstract] [Full Text] [Related]
36. Methotrexate pharmacokinetics in psoriatic patients developing hepatic fibrosis.
Jones SK; Aherne GW; Campbell MJ; White JE
Arch Dermatol; 1986 Jun; 122(6):666-9. PubMed ID: 3717976
[TBL] [Abstract][Full Text] [Related]
37. Methotrexate and the liver.
Dahl MG
Br J Dermatol; 1969 Jun; 81(6):465-7. PubMed ID: 4891127
[No Abstract] [Full Text] [Related]
38. Oral versus intravenous methotrexate: another opinion.
Kamen BA; Winick N; Holcenberg JS
J Clin Oncol; 1998 Jun; 16(6):2283-5. PubMed ID: 9626235
[No Abstract] [Full Text] [Related]
39. Biochemical modulation of 5-fluorouracil with methotrexate in advanced colorectal cancer patients pretreated with adjuvant 5-fluorouracil and leucovorin.
Pronzato P; Vaira F; Vigani A; Losardo P; Bertelli G
Anticancer Res; 1995; 15(6B):2679-82. PubMed ID: 8669846
[TBL] [Abstract][Full Text] [Related]
40. [The effect of methotrexate pharmacokinetics and of leucovorin rescue on the prognosis of osteosarcoma].
Graf N; Jost W; Müller J; Keller HE; Sitzmann FC
Klin Padiatr; 1990; 202(5):340-6. PubMed ID: 2214594
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
